跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
3-Chlorophenol
首页
药物
3-Chlorophenol
Experimental
Small Molecule
3-Chlorophenol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
6
H
5
ClO
CAS 编号
108-43-0
UNII ID
Z2Z7M2FTAD
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PROCESS FOR PREPARING FLUOXASTROBIN
申请人: ARYSTA LIFESCIENCE CORP
优先权: 2013
EP
US
2 件公开
Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism
申请人: NOVAPHARM RES AUSTRALIA
优先权: 2003
US
2 件公开
Anion receptor based on nitrofuran formyl hydrazone and phenolic hydroxyl and preparation and use of organagel thereof
申请人: UNIV NORTHWEST NORMAL
优先权: 2008
CN
7-chlorine-3a-(trifluoromethyl)-3, 3a-dihydrobenzo (d) pyrrole (2, 1-b)-oxazole-1(2H)-ketone and synthetic method thereof
申请人: UNIV SHANGHAI
优先权: 2009
CN
Derivatives of flavonoids compounds and preparation method and application thereof
申请人: UNIV TSINGHUA GRADUATE SCHOOL
优先权: 2009
CN
Method for preparing water-soluble bromochlorophenol blue
申请人: TIANJING CHEMICAL REAGENT RES INST
优先权: 2012
CN
Synthetic method of anti-tumor targeting therapy drug Tivozanib
申请人: SUZHOU MOER PHARMACEUTICAL CO LTD
优先权: 2013
CN
Method for preparing 2-amino-4-chloro-5-nitrophenol
申请人: YIXING XINYU CHEMICALS CO LTD
优先权: 2016
CN
Lenvatinib synthesizing method
申请人: HUNAN OUYA BIOLOGICAL CO LTD
优先权: 2016
CN
Preparation method of N-(2-chloro-4-hydroxyphenyl)-N'-(5-methyl-3-isoxazolyl)urea
申请人: TAILITE MEDICINE (HUBEI) CO LTD
优先权: 2017
CN
第 1 / 3 页
上一页
下一页
药物
反馈